Budesonide Shows COVID-19 Promise: Should It Be Evaluated In India?

 
• By Anju Ghangurde

UK studies indicate the potential of inhaled budesonide in improving COVID-19 recovery time in specific groups, with some leading Indian physicians suggesting that the widely available asthma/COPD therapy should be selectively evaluated in the Indian context as well.

Potential For Wider Use Of Budesonide For COVID-19? • Source: Alamy

More from COVID-19

More from Scrip